Viridans Streptococci Isolated by Culture from Blood of Cancer Patients: Clinical and Microbiologic Analysis of 50 Cases

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2006 Jan 5

PMID 16390964

Citations 45

Authors

Xiang Y Han

Mallika Kamana

Kenneth V I Rolston

Affiliations

Soon will be listed here.

Abstract

Clinical and microbiologic studies of 50 cases of viridans streptococcal bacteremia in cancer patients were performed. The bacteria were identified to species level by sequencing analysis of the 16S rRNA gene. At least nine Streptococcus spp. were found, including S. mitis (25 strains, 50.0% of 50); currently unnamed Streptococcus spp. (11 strains); S. parasanguis (five strains); S. anginosus (three strains); S. salivarius (two strains); and one strain each of S. gordonii, S. sanguis, S. sobrinus, and S. vestibularis. There were no S. oralis strains. Among 11 antibiotics of nine classes tested, no resistance to vancomycin, linezolid, or quinupristin-dalfopristin was seen. Resistance to penicillin (MIC, 4 to 12 mug/ml) was noted only among S. mitis strains (28.0%, 7/25) and not non-S. mitis strains (0/25) (P = 0.004). Significantly more S. mitis strains than non-S. mitis strains were resistant to fluoroquinolones and to > or =3 classes of antibiotics. Isolation of quinolone-resistant organisms was associated with the prior usage of quinolones (P = 0.002). Quantitative blood cultures showed that the strains resistant to levofloxacin or gatifloxacin were associated with higher colony counts than were their corresponding nonresistant strains. The young and elderly patients also had higher levels of bacteremia caused predominantly by S. mitis. Septic shock was present in 17 (34.0% of 50) patients, and 13 of those cases were caused by S. mitis (P = 0.007). These results suggest that S. mitis is the most common cause of viridans streptococcal bacteremia in cancer patients and is more resistant to antibiotics than other species.

Citing Articles

Ceftriaxone-resistant viridans streptococci bacteraemia among patients treated at a large comprehensive cancer care centre: a retrospective eighteen-year study.

Marsland P, Jain R, Tverdek F, Hendrie P, Liu C, Pergam S JAC Antimicrob Resist. 2024; 6(4):dlae126.

PMID: 39104770 PMC: 11299946. DOI: 10.1093/jacamr/dlae126.

Streptococcus taonis sp. nov., a novel bacterial species isolated from a blood culture of a patient.

Lee C, Chan C, Chida M, Miyashita M, Lee Y, Wu H Arch Microbiol. 2024; 206(4):168.

PMID: 38489085 DOI: 10.1007/s00203-024-03884-x.

Performance assessment of the Bruker Biotyper MALDI-TOF MS for the identification of difficult-to-identify viridans group streptococci.

Wan T, Lee T, Chen X, Hunag Y, Teng L, Hsueh P J Clin Microbiol. 2023; 61(12):e0114323.

PMID: 38038480 PMC: 10729738. DOI: 10.1128/jcm.01143-23.

Peritoneal Dialysis-associated Peritonitis Due to Streptococcus oralis Three Weeks after Peritoneal Dialysis Initiation.

Mihara Y, Kado H, Matsumoto K, Kurose R, Tsujinaka E, Nakai K Intern Med. 2023; 63(5):707-710.

PMID: 37438136 PMC: 10982001. DOI: 10.2169/internalmedicine.2035-23.

Clinical and microbiological characteristics of polymicrobial bacteremia: a retrospective, multicenter study.

Fukushima S, Hagiya H, Fujita K, Kamiyama S, Yamada H, Kishida M Infection. 2022; 50(5):1233-1242.

PMID: 35301683 DOI: 10.1007/s15010-022-01799-7.

References

Tarrand J, Guillot C, Wenglar M, Jackson J, Lajeunesse J, Rolston K . Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol. 1991; 29(10):2245-9. PMC: 270306. DOI: 10.1128/jcm.29.10.2245-2249.1991. View

Altschul S, Gish W, Miller W, Myers E, Lipman D . Basic local alignment search tool. J Mol Biol. 1990; 215(3):403-10. DOI: 10.1016/S0022-2836(05)80360-2. View

Elting L, Bodey G, Keefe B . Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis. 1992; 14(6):1201-7. DOI: 10.1093/clinids/14.6.1201. View

Douglas C, Heath J, Hampton K, Preston F . Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol. 1993; 39(3):179-82. DOI: 10.1099/00222615-39-3-179. View

Beighton D, Carr A, Oppenheim B . Identification of viridans streptococci associated with bacteraemia in neutropenic cancer patients. J Med Microbiol. 1994; 40(3):202-4. DOI: 10.1099/00222615-40-3-202. View

Kawamura Y, Hou X, Sultana F, Miura H, Ezaki T . Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus. Int J Syst Bacteriol. 1995; 45(2):406-8. DOI: 10.1099/00207713-45-2-406. View

Richard P, Amador Del Valle G, Moreau P, Milpied N, Felice M, Daeschler T . Viridans streptococcal bacteraemia in patients with neutropenia. Lancet. 1995; 345(8965):1607-9. DOI: 10.1016/s0140-6736(95)90117-5. View

Jacobs J, Schouten H, Stobberingh E, Soeters P . Viridans streptococci isolated from the bloodstream. Relevance of species identification. Diagn Microbiol Infect Dis. 1995; 22(3):267-73. DOI: 10.1016/0732-8893(95)00137-y. View

Doern G, Ferraro M, Brueggemann A, Ruoff K . Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother. 1996; 40(4):891-4. PMC: 163225. DOI: 10.1128/AAC.40.4.891. View

10.

Weinstein M . Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis. 1996; 23(1):40-6. DOI: 10.1093/clinids/23.1.40. View

11.

Kawamura Y, Hou X, Todome Y, Sultana F, Hirose K, Shu S . Streptococcus peroris sp. nov. and Streptococcus infantis sp. nov., new members of the Streptococcus mitis group, isolated from human clinical specimens. Int J Syst Bacteriol. 1998; 48 Pt 3:921-7. DOI: 10.1099/00207713-48-3-921. View

12.

Jacobs J, Schot C, Schouls L . Haemolytic activity of the Streptococcus milleri group' and relationship between haemolysis restricted to human red blood cells and pathogenicity in S. intermedius. J Med Microbiol. 2000; 49(1):55-62. DOI: 10.1099/0022-1317-49-1-55. View

13.

Drancourt M, Bollet C, Carlioz A, Martelin R, Gayral J, Raoult D . 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J Clin Microbiol. 2000; 38(10):3623-30. PMC: 87447. DOI: 10.1128/JCM.38.10.3623-3630.2000. View

14.

Marron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, Gudiol F . Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 2000; 31(5):1126-30. DOI: 10.1086/317460. View

15.

Alcaide F, Benitez M, Carratala J, Gudiol F, Linares J, Martin R . In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer. Antimicrob Agents Chemother. 2001; 45(2):624-6. PMC: 90340. DOI: 10.1128/AAC.45.2.624-626.2001. View

16.

Paster B, Boches S, Galvin J, Ericson R, Lau C, Levanos V . Bacterial diversity in human subgingival plaque. J Bacteriol. 2001; 183(12):3770-83. PMC: 95255. DOI: 10.1128/JB.183.12.3770-3783.2001. View

17.

Razonable R, Litzow M, Khaliq Y, Piper K, Rouse M, Patel R . Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis. 2002; 34(11):1469-74. DOI: 10.1086/340352. View

18.

Tunkel A, Sepkowitz K . Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002; 34(11):1524-9. DOI: 10.1086/340402. View

19.

Han X, Pham A, Tarrand J, Sood P, Luthra R . Rapid and accurate identification of mycobacteria by sequencing hypervariable regions of the 16S ribosomal RNA gene. Am J Clin Pathol. 2002; 118(5):796-801. DOI: 10.1309/HN44-XQYM-JMAQ-2EDL. View

20.

Kazor C, Mitchell P, Lee A, Stokes L, Loesche W, Dewhirst F . Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol. 2003; 41(2):558-63. PMC: 149706. DOI: 10.1128/JCM.41.2.558-563.2003. View